Matches in Nanopublications for { ?s ?p "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- NP193584.RA5NRNM9KLO4GQkHyECQekG9HAZUOzlFLxI0kjksjSPYM130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP193584.RA5NRNM9KLO4GQkHyECQekG9HAZUOzlFLxI0kjksjSPYM130_provenance.
- NP891618.RAaNOZdoV1d-axcZ943ytPGTp8zFVBTd7rGm_pOa7YnU0130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891618.RAaNOZdoV1d-axcZ943ytPGTp8zFVBTd7rGm_pOa7YnU0130_provenance.
- NP891623.RAZqvI6JaFeQU9_EPWdDPYb2qLsAhFBZpdmObEk9HsrqQ130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891623.RAZqvI6JaFeQU9_EPWdDPYb2qLsAhFBZpdmObEk9HsrqQ130_provenance.
- NP726421.RAZdTFDKwF818CPtFk117gVHfctaQ2ZGjFeH_gF4g0aOE130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP726421.RAZdTFDKwF818CPtFk117gVHfctaQ2ZGjFeH_gF4g0aOE130_provenance.
- NP726427.RAZaVG3tFptopDIrKcxmBEDwGaFomK34dWDqADF3GtRB8130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP726427.RAZaVG3tFptopDIrKcxmBEDwGaFomK34dWDqADF3GtRB8130_provenance.
- NP726516.RAUUKjgJjHDKV_3I6_70E7cm1ghDspHixRApSZVzi2TcI130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP726516.RAUUKjgJjHDKV_3I6_70E7cm1ghDspHixRApSZVzi2TcI130_provenance.
- assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP982940.RAX0pV06aTK8rH88dQ5PQbR6MBvBCqUKxYocezTU_2xTo130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982940.RAX0pV06aTK8rH88dQ5PQbR6MBvBCqUKxYocezTU_2xTo130_provenance.
- NP982948.RAUyNTFFTj1RQYXy0XxtBsCtetzgYoMCqN9RvncPRkrms130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982948.RAUyNTFFTj1RQYXy0XxtBsCtetzgYoMCqN9RvncPRkrms130_provenance.
- NP982947.RABI98qKy1CXtZKzcFjfspHIkeNwkl6z4WNNV8CmlKPKA130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982947.RABI98qKy1CXtZKzcFjfspHIkeNwkl6z4WNNV8CmlKPKA130_provenance.
- NP982951.RACj_zcYS-4hBwEh77gjxQ4zRAh0_cHh6P62kAPFnu3R8130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982951.RACj_zcYS-4hBwEh77gjxQ4zRAh0_cHh6P62kAPFnu3R8130_provenance.
- assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP726562.RAtW5NbPA3Ei_4o5rdaJtUqJvMpArMx5Ubk6ym8wj5IrQ130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP726562.RAtW5NbPA3Ei_4o5rdaJtUqJvMpArMx5Ubk6ym8wj5IrQ130_provenance.
- NP726627.RAqwCl_VIPZWCtQ47Fl-p4vdY-HV3EsVRjprQTGf6Pdvg130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP726627.RAqwCl_VIPZWCtQ47Fl-p4vdY-HV3EsVRjprQTGf6Pdvg130_provenance.
- NP726574.RAB5tlu2OcRYuGhYPzSDg3ll3JEBtiP1Pz1Re8eJz6bOY130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP726574.RAB5tlu2OcRYuGhYPzSDg3ll3JEBtiP1Pz1Re8eJz6bOY130_provenance.
- NP1001898.RAsOSTx17rDq1ZprixA4IMWQ_70Arm7mvmMH13b-2zDgw130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001898.RAsOSTx17rDq1ZprixA4IMWQ_70Arm7mvmMH13b-2zDgw130_provenance.
- NP982938.RAjR7HJSimZ4RfbRNGCFsM3hGcv32-Xx2BIbHO4yGzSR4130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982938.RAjR7HJSimZ4RfbRNGCFsM3hGcv32-Xx2BIbHO4yGzSR4130_provenance.
- NP982939.RApPlgpOIcgKU3cTReEprHOUULmg0m0dNwZsSyz3uJ-As130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982939.RApPlgpOIcgKU3cTReEprHOUULmg0m0dNwZsSyz3uJ-As130_provenance.
- NP982941.RAkYwIi40N1ZswrhhOyM8zAEQd1JujDOGfbsSJhnRRl0g130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982941.RAkYwIi40N1ZswrhhOyM8zAEQd1JujDOGfbsSJhnRRl0g130_provenance.
- NP982943.RAimo2VgPRbDUPrrQzmKmPxty0y3nlJyuy1QaNHnjcPuo130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982943.RAimo2VgPRbDUPrrQzmKmPxty0y3nlJyuy1QaNHnjcPuo130_provenance.
- NP982945.RAs1j7rkwMJ4luFe7zBSr8JrT451BPL-JbwovB1laATYo130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982945.RAs1j7rkwMJ4luFe7zBSr8JrT451BPL-JbwovB1laATYo130_provenance.
- NP982949.RAlZllMzrbpHs9CHWSnQciWP-QIJSr8u3BjHcxF4M9IqU130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982949.RAlZllMzrbpHs9CHWSnQciWP-QIJSr8u3BjHcxF4M9IqU130_provenance.
- NP982950.RAj1TxzTd1XSNVLwllkirvsjUdklY4gAq5MMOoSFVfg6k130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982950.RAj1TxzTd1XSNVLwllkirvsjUdklY4gAq5MMOoSFVfg6k130_provenance.
- NP1001914.RANZ3o6h7LFk6bMIuvHtqIYriTEwaohu3LCgNNAuikPYg130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001914.RANZ3o6h7LFk6bMIuvHtqIYriTEwaohu3LCgNNAuikPYg130_provenance.
- NP726499.RAM0MMysTQ-2N8dMznHdS-aKQ1B-Xd2JTOzPNAIUbhSss130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP726499.RAM0MMysTQ-2N8dMznHdS-aKQ1B-Xd2JTOzPNAIUbhSss130_provenance.
- NP726622.RAPqChUBFH1Qv5yRGvpxhy-EhgBHv_6bC0fskoURXL2gw130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP726622.RAPqChUBFH1Qv5yRGvpxhy-EhgBHv_6bC0fskoURXL2gw130_provenance.
- NP982944.RA4VoZv1fTVjoqWrbw6LgWSNGZ2DJYn4dPL6Yt8K6CrJQ130_assertion description "[As expected, HTS of TCRB and TCRG identified MRD that was not detected by flow cytometry in a subset of cases (25 of 35 HTS compared with 13 of 35, respectively), which highlights the potential of this technology to define lower detection thresholds for MRD that could affect clinical treatment decisions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982944.RA4VoZv1fTVjoqWrbw6LgWSNGZ2DJYn4dPL6Yt8K6CrJQ130_provenance.